-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

641. Chronic Lymphocytic Leukemias: Basic and Translational: Poster III

Symposia: Chronic Lymphocytic Leukemias: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Jessica Nunes1, Ann Ventura2*, Kevan Zapolnik, BS3*, Xiaokui Mo, PhD, MAS4*, Liwen Zhang2*, John C. Byrd, MD5, Christoph Rader, Ph.D.6* and Natarajan Muthusamy, DVM, PhD3

1MCDB Program, Ohio State University, Columbus, OH
2The Ohio State University, Columbus, OH
3Comprehensive Cancer Center, The Ohio State University, Columbus, OH
4Department of Biomedical informatics, college of medicine, The Ohio State University, Columbus, OH, USA, columbus, OH
5University of Cincinnati College of Medicine, Cincinnati, OH
6Scripps Research, Jupiter, FL

Susan Klaeger1,2*, Eugen Tausch, MD3, Binyamin A. Knisbacher, PhD1*, Annie Apffel, BA1*, Karl R Clauser, BS1*, Corinne Williams1*, Clary Clish1*, Laura Z. Rassenti, PhD4, Thomas J. Kipps, MD, PhD4, Kirsten Fischer, MD5*, Michael Hallek, MD5, Michael A Gillette6*, Donna S. Neuberg, ScD7, Gad Getz, PhD1,8,9*, DR Mani, PhD6*, Stephan Stilgenbauer, MD3, Catherine J. Wu, MD1,10,11,12 and Steven A Carr, PhD6*

1Broad Institute of MIT and Harvard, Cambridge, MA
2Genentech Inc., South San Francisco, CA
3Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
4Moores Cancer Center, University of California, San Diego, La Jolla, CA
5Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University Hospital Cologne, Cologne, Germany
6Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
7Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
8Department of Medicine, Harvard Medical School, Boston, MA
9Department of Pathology, Massachusetts General Hospital Cancer Center, Boston, MA
10Department of Medicine, Brigham and Women's Hospital, Boston, MA
11Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
12Harvard Medical School, Boston, MA

Lisa Brandmeier, MSc1,2*, Veronika Ecker1,2*, Martina Stumpf1,2*, Piero Giansanti2,3,4*, Aida Varela Moreira5*, Lisa Pfeuffer1,2*, Marcel Fens5*, Junyan Lu6*, Bernhard Küster, PhD3,7,8*, Thomas Engleitner2,9*, Simon Heidegger10*, Ingo Ringshausen11, Thorsten Zenz12, Clemens-Martin Wendtner13, Markus Müschen, MD14, Jürgen Ruland1,2,7,8* and Maike Buchner1,2*

1Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany
2TranslaTUM - Central Institute for Translational Cancer Research, Technical University of Munich, Munich, Germany
3Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany
4Bavarian Center for Biomolecular Mass Spectrometry at the University hospital rechts der Isar (BayBioMS@MRI), Technical University of Munich, Munich, Germany
5Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
6European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
7German Cancer Consortium (DKTK), Munich Partner Site, Munich, Germany
8German Cancer Research Center (DKFZ), Heidelberg, Germany
9Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich, Germany
10Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany
11Wellcome Trust/MRC Cambridge Stem Cell Institute and Department of Haematology, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom
12Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, BW, Switzerland
13Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University, Munich, Germany
14Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT

Prajish Iyer, PhD1*, Bo Zhang, MD, PhD2, Tingting Liu3*, Meiling Jin1*, Kevyn Hart4*, Joo Y. Song, MD5,6, Wing C Chan, MD5,6*, Tanya Siddiqi, MD7, Alexey V Danilov, MD6,7, Steve T Rosen, MD6,7 and Lili Wang, MD-PhD1,6

1Department of Systems Biology, Beckman Research Institute, City of Hope, Monrovia, CA
2Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3City of Hope, Duarte, CA
4Department of Human Genetics Human Genetics, University of California, Los Angeles, Los Angeles, CA
5Department of Pathology, City of Hope National Medical Center, Duarte, CA
6Toni Stephenson Lymphoma Center, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA
7Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Erika Tissino, PhD1*, Nicola Calonaci2*, Federico Pozzo, PhD1*, Gabriela Forestieri3*, Lodovico Terzi Di Bergamo3*, Filippo Vit1*, Annalisa Gaglio1*, Riccardo Bergamin2*, Salvatore Milite4*, Stefano Cozzini5*, Maria Ilaria Del Principe, MD6*, Roberta Laureana, MD6*, Annalisa Chiarenza7*, Jacopo Olivieri8*, Francesco Zaja9*, Cristoforo Fabbris10*, Valentina Lupato10*, Riccardo Bomben, PhD1*, Davide Rossi, MD, PhD3, Valter Gattei, MD1, Antonella Zucchetto, PhD1* and Giulio Caravagna2*

1Clinical and Experimental Onco-Hematology Unit, Centro Di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy
2Cancer Data Science Laboratory, University of Trieste, Trieste, Italy
3Institute of Oncology Research, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
4Fondazione Human Technopole, Milano, Italy
5Area Science Park, Trieste, Italy
6Ematologia, Dipartimento di Biomedicina e Prevenzione, Università degli studi di Roma Tor Vergata, Roma, Italy
7Divisione di Ematologia, Ospedale Ferrarotto, A.O.U. Policlinico-OVE, Università di Catania, Catania, Italy
8Azienda Sanitaria Universitaria Integrata Santa Maria della Misericordia, Udine, Italy
9Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy
10SOC Otorinolaringoiatria, Azienda Sanitaria Friuli Occidentale, Pordenone, Italy

Clare Sun, MD1, Melih Acar2*, David Jenkins3*, Barrett Nuttall3*, Rafael White2*, Veerendra Munugalavadla2 and Adrian Wiestner, MD, PhD1

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2AstraZeneca, South San Francisco, CA
3AstraZeneca, Waltham, MA

Judith Mateos-Jaimez1*, Maurizio Mangolini, PhD2*, Anna Vidal, PhD1*, Dolors Colomer, PhD1,3,4,5*, Elías Campo, PhD MD1,3,4,5, Ingo Ringshausen2, José I. Martín-Subero, PhD1,3,5,6* and Alba Maiques-Diaz, PhD1*

1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
2Wellcome Trust/MRC Cambridge Stem Cell Institute and Department of Haematology, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom
3Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
4Hematopathology Section, Pathology Department, Hospital Clinic, Barcelona, Spain
5Universitat de Barcelona, Barcelona, Spain
6Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

Paul Hengeveld1,2, Pieter M. Kolijn, MSc1*, Jeroen A.A. Demmers, PhD3*, Wouter Doff, BSc.3*, Julie M.N. Dubois, MD, PhD4*, Melissa Rijken5*, Jorn Assmann, PhD1*, Lina Van Der Straten, MD1,2*, Henk-Jan Boiten, MD, PhD, MSc1*, Kirsten J. Gussinklo5*, Peter J.M. Valk, PhD5, Peter E. Westerweel, MD, PhD2*, Arnon P. Kater, MD, PhD6, Anton W. Langerak, PhD1* and Mark-David Levin2

1Department of Immunology, Erasmus MC, Rotterdam, Netherlands
2Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
3Proteomics Center, Erasmus MC, Rotterdam, Netherlands
4Department of Hematology, Amsterdam University Medical Centers, Amsterdam, Netherlands
5Department of Hematology, Erasmus MC, Rotterdam, Netherlands
6Academic Medical Center, Amsterdam Zuidoost, NH, Netherlands

Kiyomi Mashima, MD, PhD1,2,3, Benjamin L. Lampson, MD, PhD2,3,4, Aditi Gupta, PhD5*, Nicholas Moore, M.D.2,3,5*, Anna Petrackova6*, Samantha J. Shupe, BS4,7*, Stacey M. Fernandes, BS8,9*, Amaro Taylor-Weiner, PhD3*, Riaz Gillani, M.D.2,3,10,11*, Hoyin Chu, BS3,12*, Seunghun Han, BS5,13*, Sabrina Camp5,13*, Eric Kofman, BS3,5*, Gad Getz, PhD3,14*, Catherine J. Wu, MD3,7,15, Eliezer Van Allen, MD3,12*, Saud H AlDubayan, MD3,7,12* and Jennifer R. Brown, MD, PhD7,9,16

1Division of Medical Oncology, CLL Center, Dana-Farber Cancer Institute, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Dana-Farber Cancer Institute, Boston, MA
6Department of Immunology, Palacky University Olomouc, Olomouc, Czech Republic
7Harvard Medical School, Boston, MA
8Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
9Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
10Boston Children's Hospital, Boston, MA
11Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
12Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
13Broad Institute, Cambridge
14Center for Cancer Research, Massachusetts General Hospital, Boston, MA
15Department of Medical Oncology, Dana-Farber Cancer Institute, Inc, Boston, MA
16Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, MA

Alicia Vaca, PhD1*, Mariela Sivina, PhD1*, Ekaterina Kim, PhD, MS2*, Alessandra Ferrajoli2, William G. Wierda, MD, PhD3 and Jan A. Burger, MD, PhD2

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3The University of Texas M.D. Anderson Cancer Center, Houston, TX

Jyotsana Singh, PhD1*, Daisy Diaz Rohena1*, Chaomei Liu1*, Bailey Slawin1*, Janani Ravikrishnan, PhD2, Nitin Jain, MD3, William G. Wierda, MD, PhD4, Kai Zhang, MD5*, Michael Niesman, PhD5*, Jennifer A. Woyach, MD2 and Deepa Sampath, PhD1

1Department of Hematopoietic Biology & Malignancy, The University of Texas, MD Anderson Cancer Center, Houston, TX
2Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH
3Department of Leukemia, MD Anderson Cancer Center, Houston, TX
4The University of Texas M.D. Anderson Cancer Center, Houston, TX
5MingSight Pharmaceuticals, Inc., San Diego, CA

Gonzalo Blanco1,2*, Florencia Palacios3*, Kamala Vanarsa4*, Poojitha Dugyala4*, Pui Yan Chiu5*, Steven L Allen, MD1,6,7, Yasmine Kieso, MSCR1*, Anna Puiggros, PhD8*, Jacqueline C. Barrientos, MD, MS9,10,11, Xavier Calvo, MD, PhD12*, Jonathan E. Kolitz, MD1,13,14, Eva Gimeno15*, Joanna M. Rhodes, MD, MSCE1,7,16, Ana Ferrer, MD, PhD12*, Kanti R Rai, MD1,14,17, Barbara Sherry, PhD18,19, Blanca Espinet, PhD12*, Chandra Mohan4* and Nicholas Chiorazzi, MD1,9,14

1Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY
2Hospital del Mar Medical Research Institute (IMIM), Hospital del Mar, Barcelona, Spain
3Institut Pasteur Montevideo, Montevideo, URY
4Biomedical Engineering & Medicine, University of Houston, Houston, TX
5Center for Immunology & Inflammation, The Feinstein Institute for Medical Research, Manhasset, NY
6Department of Medicine, Division of Hematology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
7Department of Medicine, North Shore University Hospital and Long Island Jewish Medical Center, Northwell Health, Manhasset, NY
8Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
9North Shore University Hospital, Northwell Health, Manhasset, NY
10Karches Center for Chronic Lymphocytic Leukemia Research, The Feinstein Institute for Medical Research, Northwell Health, Manhasset
11Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
12Group of Translational Research on Hematological Neoplasms, Hospital del Mar-IMIM, Barcelona, Spain
13Monter Cancer Center, North Shore University Hospital and Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY
14Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
15Dr. Aiguader, 88, IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain
16Donald Zucker School of Medicine, Hempstead, NY
17Department of Medicine, Northwell Health, Manhasset, NY
18Departments of Medicine and of Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
19Center for Immunology and Inflammation, The Feinstein Institute for Medical Research, Northwell Health System, Manhasset, NY

Natalia Timofeeva, MD1*, Varsha Gandhi, PhD2, Marina Konopleva, MD, PhD3,4 and Mary Ayres5*

1University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Experimental Therapeutics, Univ. of Texas M.D. Anderson Cancer Center, Houston, TX
3MD Anderson Cancer Center, Houston, TX
4Albert Einstein College of Medicine, Bronx, NY
5U.T. M.D. Anderson Cancer Center, Houston, TX

*signifies non-member of ASH